This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of the project is to determine the prevalence of primary iron overload in the African-American and Hispanic population of the Washington, D.C. area as part of a 5-year nationwide iron overload screening program b the National Institutes of Health. The primary hypothesis of the study is that non-HFE primary iron overload exists in the African American population. Year 1 will be devoted to planning, protocol development and pilot testing. In Years 2 and 3, an intial screening program, by determining the transferrin saturation and serum ferritin concentration in 20,000 subjects, will be conducted. Approximately 16,000 African American and 4,000 Hispanic patients will be screened at primary care facilities of Howard University Hospital and other institutions. Subjects with transferrin saturation and/or serum ferritin concentration above the 97.5 percentile (projected to be about 4.9% of the total or 980 subjects) will be followed up with a repeat determination of transferrin saturation and serum ferritin concentration. Subjects with confirmed elevations (projected to be about 20% of the subjects having repeat determinations or about 198 individuals) will undergo comprehensive clinical examinations during Years 2, 3 and 4. It is projected that primary iron overload will be found in about one-half (100) of the subjects undergoing comprehensive examination, and family studies will be performed on approximately 400 relatives of these subjects during Years 3 and 4. Subjects with primary iron overload will be followed during Years 2 to 5 of the study, with regards to morbidity and mortality. Assessments of Ethical, Legal and Social Issues (ELSI) will be done throughout the research program.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
2M01RR010284-11
Application #
7378662
Study Section
Special Emphasis Panel (ZRR1-CR-8 (02))
Project Start
2006-07-15
Project End
2007-02-28
Budget Start
2006-07-15
Budget End
2007-02-28
Support Year
11
Fiscal Year
2006
Total Cost
$49,140
Indirect Cost
Name
Howard University
Department
Type
Schools of Medicine
DUNS #
056282296
City
Washington
State
DC
Country
United States
Zip Code
20059
Christensen, Kurt D; Uhlmann, Wendy R; Roberts, J Scott et al. (2018) A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone. Genet Med 20:132-141
Doumatey, Ayo P; He, William J; Gaye, Amadou et al. (2018) Circulating MiR-374a-5p is a potential modulator of the inflammatory process in obesity. Sci Rep 8:7680
Guan, Yue; Roter, Debra L; Wolff, Jennifer L et al. (2018) The impact of genetic counselors' use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer's disease. Patient Educ Couns 101:817-823
Mullins, Tanya L Kowalczyk; Li, Su X; Bethel, James et al. (2018) Sexually transmitted infections and immune activation among HIV-infected but virally suppressed youth on antiretroviral therapy. J Clin Virol 102:7-11
Faruque, Mezbah U; Chen, Guanjie; Doumatey, Ayo P et al. (2017) Transferability of genome-wide associated loci for asthma in African Americans. J Asthma 54:1-8
Guan, Yue; Roter, Debra L; Erby, Lori H et al. (2017) Disclosing genetic risk of Alzheimer's disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study. Patient Educ Couns 100:927-935
Nandakumar, Priyanka; Lee, Dongwon; Richard, Melissa A et al. (2017) Rare coding variants associated with blood pressure variation in 15?914 individuals of African ancestry. J Hypertens 35:1381-1389
Lieberman, Richard; Armeli, Stephen; Scott, Denise M et al. (2016) FKBP5 genotype interacts with early life trauma to predict heavy drinking in college students. Am J Med Genet B Neuropsychiatr Genet 171:879-87
Christensen, Kurt D; Roberts, J Scott; Whitehouse, Peter J et al. (2016) Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial. Ann Intern Med 164:155-63
Armeli, Stephen; O'Hara, Ross E; Covault, Jon et al. (2016) Episode-specific drinking-to-cope motivation and next-day stress-reactivity. Anxiety Stress Coping 29:673-84

Showing the most recent 10 out of 205 publications